Nature Communications · 2019 · 131 citations · 46 references
PharmacyOncologyPharmacologyDrug DeliveryGene DeliveryGene TherapyAntifibrotic TherapyCancer NanomedicineFibrosisHepatic FibrosisMetastatic Disease TreatmentNanomedicineActivated Hepatic Stellate CellsBreast Cancer Liver MetastasisColorectal Liver MetastasisGene-targeted TherapyLipid NanoparticlesLiver Fibrosis ProgressionLiver Metastases TreatmentPancreatic Cancer Liver Metastasis
Activated hepatic stellate cell (aHSC)-mediated liver fibrosis is essential to the development of liver metastasis. Here, we discover intra-hepatic scale-up of relaxin (RLN, an anti-fibrotic peptide) in response to fibrosis along with the upregulation of its primary receptor (RXFP1) on aHSCs. The elevated expression of RLN serves as a natural regulator to deactivate aHSCs and resolve liver fibrosis. Therefore, we hypothesize this endogenous liver fibrosis repair mechanism can be leveraged for liver metastasis treatment via enforced RLN expression. To validate the therapeutic potential, we utilize aminoethyl anisamide-conjugated lipid-calcium-phosphate nanoparticles to deliver plasmid DNA encoding RLN. The nanoparticles preferentially target metastatic tumor cells and aHSCs within the metastatic lesion and convert them as an in situ RLN depot. Expressed RLN reverses the stromal microenvironment, which makes it unfavorable for established liver metastasis to grow. In colorectal, pancreatic, and breast cancer liver metastasis models, we confirm the RLN gene therapy results in significant inhibition of metastatic progression and prolongs survival. In addition, enforced RLN expression reactivates intra-metastasis immune milieu. The combination of the RLN gene therapy with PD-L1 blockade immunotherapy further produces a synergistic anti-metastatic efficacy. Collectively, the targeted RLN gene therapy represents a highly efficient, safe, and versatile anti-metastatic modality, and is promising for clinical translation.
46
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa‐Silva, Nicole M. Aiello, Allyson J. Ocean et al. · Nature Cell Biology · 2015 · 2.7K citations · Full text
Medicine, Cancer Biology, Oncology +14
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto, Tze Mun Loo, Koji Atarashi et al. · Nature · 2013 · 2.2K citations
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Clifford J. Whatcott, Caroline H. Diep, Ping Jiang et al. · Clinical Cancer Research · 2015 · 635 citations